AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am a Senior Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
Curiosity line blue background

Aviation Autonomy Phase 2: the Future of UAS Traffic Management in the UK

5 minutes Jul 10 2025

Read More
Curiosity line teal background

Sprinting to an IPO? ASIC trials a streamlined fast-track to the ASX

Jul 08 2025

Read More
featured image

Update on German customer installations: The Federal Court of Justice's reasons for its decision

4 minutes Jul 07 2025

Read More